Rosiglitazone: a European regulatory perspective

Eberhard Blind,Eberhard Blind,K. Dunder,P. Graeff,E. Abadie
DOI: https://doi.org/10.1007/s00125-010-1992-5
IF: 8.2
2011-02-01
Diabetologia
Abstract:
What problem does this paper attempt to address?